Compare · KMTS vs MDLN
KMTS vs MDLN
Side-by-side comparison of Kestra Medical Technologies Ltd. (KMTS) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both KMTS and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 28.1x KMTS ($1.71B).
- Over the past year, KMTS is up 10.4% and MDLN is down 11.8% - KMTS leads by 22.1 points.
- MDLN has been more active in the news (7 items in the past 4 weeks vs 6 for KMTS).
- MDLN has more recent analyst coverage (25 ratings vs 9 for KMTS).
PerformanceKMTS+1.34%MDLN-11.77%
2025-12-17+0.00%2026-10-16
- Company
- Kestra Medical Technologies Ltd.
- Medline Inc.
- Price
- $27.16-5.20%
- $35.95-1.74%
- Market cap
- $1.71B
- $48.08B
- 1M return
- +11.61%
- +11.97%
- 1Y return
- +10.36%
- -11.77%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2025
- News (4w)
- 6
- 7
- Recent ratings
- 9
- 25
Latest KMTS
- Director Cohen Raymond W sold $97,504 worth of shares (3,330 units at $29.28), decreasing direct ownership by 6% to 54,790 units (SEC Form 4) (tax liability)
- Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies
- SEC Form 144 filed by Kestra Medical Technologies Ltd.
- CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors
- Director Kwo Elizabeth sold $97,268 worth of shares (4,010 units at $24.26), decreasing direct ownership by 22% to 14,116 units (SEC Form 4) (withholding obligation)
- SEC Form 144 filed by Kestra Medical Technologies Ltd.
- SEC Form 10-Q filed by Kestra Medical Technologies Ltd.
- Kestra Medical Technologies Ltd. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
- Director Schwartz Jeffrey Lawrence sold $97,942 worth of shares (3,890 units at $25.18) and was granted 7,217 shares, increasing direct ownership by 30% to 14,236 units (SEC Form 4) to satisfy tax liability
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M